CClinicalTrials.gg
CompletedNCT02362607Updated Feb 4, 2016

Integrated Diabetes Management Protocol Using Smartphone

An interventional study of Integrated Diabetes Management Protocol and Standard Diabetes Management Protocol in Diabetes, sponsored by Chungbuk National University. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-02-04.

Sponsored by Chungbuk National University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The investigators aim to assess whether using integrated diabetes management protocol using smartphone would increase glucose control among diabetes patients.

Read the detailed description

Smartphones and digital healthcare is expected to provide better diabetes care. The investigators aim to assess whether using integrated diabetes management protocol using smartphone would increase glucose control among diabetes patients.

Smartphone apps for food diary, activity monitor, blood glucose will be used for three months.

Blood glucose control and patient satisfaction will be assessed.

02

Conditions studied

  • Diabetes

Browse trials for

03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 40 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Chungbuk National University is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Type 2 diabetes, type 1 diabetes, gestational diabetes

Exclusion criteria

Exclusion Criteria:

  • Medications which interfere glucose control
  • Cancer
  • Chronic kidney injury
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Integrated Diabetes Management Protocol

    Smartphone apps for food diary, activity monitor, blood glucose will be used for three months.

    Behavioral: Integrated Diabetes Management Protocol

  • Active comparator
    Standard Diabetes Management Protocol

    Subjects will receive standard diabetes management protocol with standard education and standard blood glucose measurement devices.

    Behavioral: Standard Diabetes Management Protocol

Interventions

  • BehavioralIntegrated Diabetes Management Protocol
  • BehavioralStandard Diabetes Management Protocol
06

What researchers measure

Primary outcomes

  1. Blood Glucose Control Status Measured by HbA1c

    Blood test results for HbA1c after three months.

    Time frame: After three months

Secondary outcomes

  1. Patient Satisfaction Measured by Questionnaire

    Summary of Diabetes Self-Care Activities Measure (SDSCA) Questionnaire (Toobert et al., 2000)

    Time frame: After three months

07

Study locations

1 site
  • Chungbuk National University
    Cheongju, Chungcheongbuk-Do 361-711, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02362607
Lead sponsor
Chungbuk National University
Responsible party
Hyung Jin Choi (Clinical Assistant Professor, Chungbuk National University) — Principal investigator
First posted
Feb 13, 2015
Start date
Feb 2015
Primary completion
Oct 2015
Last update
Feb 4, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion